CompletedNot Applicable

Lignocaine Nebulization Versus Airway Block for Awake Nasal Fiberoptic Intubation in Patients With Head and Neck Burns.

Egypt100 participantsStarted 2022-09-23

Plain-language summary

This study evaluates the efficacy and ease of lignocaine nebulization to deliver anesthesia to the upper airway of patients with head and neck burns undergoing reconstructive surgery in need of awake nasal fiberoptic intubation compared to the traditional upper airway nerve block.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients above 18 years with ASA classification II, III, and no known hypersensitivity for local anesthetics Exclusion Criteria: * Patient refusal * Patients under 18 years * Patients suffering from coagulopathies or bleeding tendencies * Patients with ASA 4 classification * Non cooperative patients * Patients undergoing extensive facial reconstruction * Patients with known hypersensitivity to lignocaine.

What they're measuring

Patient comfort during performing awake nasal fiberoptic intubation

Timeframe: 5 minutes

Time to performing awake nasal fiberoptic intubation

Timeframe: 5 minutes

Trial details

NCT IDNCT05550051

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-02

View on ClinicalTrials.gov More Practicality, Efficacy, and Ease of Lignocaine Nebulization Compared to Traditional Upper Airway Block for Awake Nasal Fiberoptic Intubation trials